Lunit and Microsoft Collaborate to Advance AI-Driven Cancer Diagnosis
This underscores Lunit's long-term vision to move beyond standalone AI tools—toward building integrated solutions that align with real-world clinical practice. By joining forces with Microsoft, Lunit is poised to deliver scalable technologies that not only streamline radiology workflows but also drive measurable improvements in diagnostic consistency and patient care across diverse healthcare settings.
This marks a significant milestone in Lunit's mission to expand access to AI tools, particularly in the U.S. market, by leveraging Microsoft Azure's global cloud infrastructure and deep expertise in healthcare-focused AI technologies.
Key highlights of the collaboration include:
- Co-Development of AI Model Customization Service on Azure: Lunit and Microsoft collaborate to develop a service that allows fine-tuning of AI models using site-specific clinical data from each customer. This approach helps mitigate cross-site model performance variability—one of the key challenges in deploying AI in real-world clinical environments—and ensures more reliable, tailored outcomes in diverse clinical settings.
- Leveraging Microsoft's AI Platform for Innovative Workflow Solutions: Moving beyond point solutions, Lunit will leverage Microsoft's agentic AI frameworks—designed to support intelligent task automation—to develop end-to-end workflow automation tools. These solutions aim to simplify clinical decision-making and enhance operational efficiency across the care continuum.
"For AI to truly make an impact in healthcare, it must be accessible, scalable, and seamlessly integrated into clinical practice," said Brandon Suh, CEO of Lunit. "Our collaboration with Microsoft enables us to bring our AI to more providers through trusted platforms like Microsoft Azure, helping us expand access in the U.S. and beyond. This collaboration brings us one step closer to delivering high-quality, consistent care through AI—at scale."
"With Microsoft Azure, we are shaping an ecosystem that supports partners like Lunit in delivering scalable AI innovations," said Naveen Valluri, General Manager, Health and Life Sciences Data and AI at Microsoft. "By combining our infrastructure with clinical-grade AI developed in close collaboration with leaders like Lunit, we're accelerating the development of intelligent, integrated solutions for radiology and beyond."
About Lunit
Founded in 2013, Lunit (KRX:328130.KQ) is a global leader in AI for cancer diagnostics and therapeutics. With a mission to conquer cancer through AI, Lunit develops AI-powered solutions for medical imaging and biomarker analysis to enable precise diagnosis and personalized treatment. Lunit's FDA-cleared Lunit INSIGHT suite supports cancer screening at over 6,500 medical institutions in more than 65 countries. Lunit clinical studies have been featured in top-tier journals—including The Lancet Digital Health and Journal of Clinical Oncology —and presented at major conferences such as ASCO and RSNA. Headquartered in Seoul with global offices, Lunit is driving the worldwide fight against cancer. Learn more at lunit.io.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
11 hours ago
- Korea Herald
KT unveils upgraded Korean LLM, eyes sovereign AI lead
Korean telecommunications giant KT Corp. on Thursday unveiled its upgraded large language model, Mi:dm 2.0, optimized for the Korean language, expressing its commitment to expanding the open-source artificial intelligence ecosystem and participating in the government's sovereign AI initiative. 'KT seeks to embed four key principles across all domains of AI: data sovereignty, user choice, Korean values and responsible operations,' said Shin Dong-hoon, chief AI officer at KT, during an online press briefing. 'Mi:dm 2.0 is the first model developed under our sovereign AI philosophy.' The telecom company is positioning itself as a strong contender in the government's foundational AI model development project, which is recruiting domestic AI consortia until July 21. If selected, participants can label their model as a "K-AI model," and their company as a "K-AI enterprise." "Because our AI philosophy aligns with the government's direction, we are preparing to participate in the sovereign AI foundation model project," Shin said. 'Over the past year, in collaboration with data alliance, we have built a model that embodies Korean values and culture — a major advantage in establishing a uniquely Korean AI." The Mi:dm 2.0 lineup comprises two models: the Mi:dm 2.0 base, featuring 11.5 billion parameters, and the lighter Mi:dm 2.0 mini, which has 2.3 billion parameters. Both support Korean and English, reflecting KT's ambition to lead with 'Korean AI' — a concept that refers to AI developed from Korea's ethos, knowledge and way of life. As part of its two-track strategy, KT is also enhancing Mi:dm 2.0 while co-developing a Korean-specialized version of GPT-4 in partnership with US IT giant Microsoft. 'We have never believed in giving up on our technology,' said the CAIO. 'Where we lack capabilities, we intend to collaborate with Microsoft to tune ChatGPT in a way that deeply understands Korean culture and values.' The telecom giant first commercialized its large-scale AI model in 2022 and has since integrated it into services like its AI contact center. The company said the upgraded LLM outperforms leading domestic and global models in understanding and generating Korean-language content, especially in culturally nuanced or professional domains. 'Our goal is to infuse the Korean spirit into every layer of our AI model lineup,' said Oh Seung-phil, chief technology officer. 'That is our mission and our philosophy.'
Korea Herald
a day ago
- Korea Herald
Lunit and Microsoft Collaborate to Advance AI-Driven Cancer Diagnosis
SEOUL, South Korea, July 2, 2025 /PRNewswire/ -- Lunit (KRX: a leading provider of AI for cancer diagnostics and therapeutics, today announced a collaboration with Microsoft to accelerate the delivery of AI-powered healthcare solutions. In conjunction with their recent acquisition of Volpara, a Microsoft Industry Health Certified Partner, this collaboration will give health professionals globally access to tools that will assist in the detection of cancer. This underscores Lunit's long-term vision to move beyond standalone AI tools—toward building integrated solutions that align with real-world clinical practice. By joining forces with Microsoft, Lunit is poised to deliver scalable technologies that not only streamline radiology workflows but also drive measurable improvements in diagnostic consistency and patient care across diverse healthcare settings. This marks a significant milestone in Lunit's mission to expand access to AI tools, particularly in the U.S. market, by leveraging Microsoft Azure's global cloud infrastructure and deep expertise in healthcare-focused AI technologies. Key highlights of the collaboration include: - Co-Development of AI Model Customization Service on Azure: Lunit and Microsoft collaborate to develop a service that allows fine-tuning of AI models using site-specific clinical data from each customer. This approach helps mitigate cross-site model performance variability—one of the key challenges in deploying AI in real-world clinical environments—and ensures more reliable, tailored outcomes in diverse clinical settings. - Leveraging Microsoft's AI Platform for Innovative Workflow Solutions: Moving beyond point solutions, Lunit will leverage Microsoft's agentic AI frameworks—designed to support intelligent task automation—to develop end-to-end workflow automation tools. These solutions aim to simplify clinical decision-making and enhance operational efficiency across the care continuum. "For AI to truly make an impact in healthcare, it must be accessible, scalable, and seamlessly integrated into clinical practice," said Brandon Suh, CEO of Lunit. "Our collaboration with Microsoft enables us to bring our AI to more providers through trusted platforms like Microsoft Azure, helping us expand access in the U.S. and beyond. This collaboration brings us one step closer to delivering high-quality, consistent care through AI—at scale." "With Microsoft Azure, we are shaping an ecosystem that supports partners like Lunit in delivering scalable AI innovations," said Naveen Valluri, General Manager, Health and Life Sciences Data and AI at Microsoft. "By combining our infrastructure with clinical-grade AI developed in close collaboration with leaders like Lunit, we're accelerating the development of intelligent, integrated solutions for radiology and beyond." About Lunit Founded in 2013, Lunit (KRX: is a global leader in AI for cancer diagnostics and therapeutics. With a mission to conquer cancer through AI, Lunit develops AI-powered solutions for medical imaging and biomarker analysis to enable precise diagnosis and personalized treatment. Lunit's FDA-cleared Lunit INSIGHT suite supports cancer screening at over 6,500 medical institutions in more than 65 countries. Lunit clinical studies have been featured in top-tier journals—including The Lancet Digital Health and Journal of Clinical Oncology —and presented at major conferences such as ASCO and RSNA. Headquartered in Seoul with global offices, Lunit is driving the worldwide fight against cancer. Learn more at
Korea Herald
a day ago
- Korea Herald
GS Group chair pushes for rapid AI adoption
GS Group announced Wednesday that it held an artificial intelligence-themed forum on Tuesday, bringing together industry experts to discuss the current state and future of AI agents. The group's third GenAI Connect Day spotlighted AI's real-world use cases, a shift from the conceptual discussions of past events, while fostering collaboration opportunities among AI practitioners. Speakers who shared insights on the latest AI agent technologies and their practical applications included key figures behind GS's AI transformation platform MISO; Klaire Baek, staff manager of Microsoft's GitHub Copilot; Craig Doeden and Edward Kong from US AI startup Articul8; and Lee Kyung-rok, CEO of AI solution developer BrainCrew. The group's efforts to promote AI knowledge exchange reflect Chairman Huh Tae-soo's philosophy, which calls for the rapid integration of AI across industries as a 'critical engine' for enhancing the competitiveness of Korean companies. In this vein, GS Group also aims to embed AI capabilities across its businesses, as demonstrated by the recent launch of its AX platform MISO and the regular hosting of group hackathons to drive digital transformation. 'AI is no longer just a choice but a survival tactic,' a GS Group official said. 'We will continue to foster knowledge exchange to help grow the AI ecosystem.'
